Literature DB >> 25976187

Aceruloplasminaemia: a rare but important cause of iron overload.

Adam Doyle1, Ferry Rusli1, Prithi Bhathal2.   

Abstract

We present a case of a 20-year-old man referred to our service with iron overload and mildly deranged liver biochemistry. Although liver histopathology was consistent with haemochromatosis, iron studies were not consistent with this diagnosis. Serum ceruloplasmin levels were undetectable, leading to a diagnosis of aceruloplasminaemia. Unlike other iron overload disorders, neurological complications are a unique feature of this illness, and often irreversible, once established. The patient was treated with iron chelation prior to the onset of neurological injury, and experienced progressive normalisation of his ferritin and liver biochemistry. This is one of the youngest diagnosed cases in the published literature and, crucially, was a rare case of diagnosis and treatment prior to the onset of neurological sequelae. This is presented alongside a review of previously published cases of aceruloplasminaemia, including responses to iron chelation therapy. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25976187      PMCID: PMC4434379          DOI: 10.1136/bcr-2014-207541

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

Review 1.  Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.

Authors:  Z L Harris; L W Klomp; J D Gitlin
Journal:  Am J Clin Nutr       Date:  1998-05       Impact factor: 7.045

2.  Desferrioxamine treatment of aceruloplasminemia: Long-term follow-up.

Authors:  Ping-Lei Pan; He-Han Tang; Qin Chen; Wei Song; Hui-Fang Shang
Journal:  Mov Disord       Date:  2011-05-18       Impact factor: 10.338

Review 3.  A case of hereditary ceruloplasmin deficiency with iron deposition in the brain associated with chorea, dementia, diabetes mellitus and retinal pigmentation: administration of fresh-frozen human plasma.

Authors:  M Yonekawa; T Okabe; Y Asamoto; M Ohta
Journal:  Eur Neurol       Date:  1999       Impact factor: 1.710

Review 4.  Aceruloplasminemia.

Authors:  J D Gitlin
Journal:  Pediatr Res       Date:  1998-09       Impact factor: 3.756

Review 5.  The neurological presentation of ceruloplasmin gene mutations.

Authors:  Alisdair McNeill; Massimo Pandolfo; Jens Kuhn; Huifang Shang; Hiroaki Miyajima
Journal:  Eur Neurol       Date:  2008-07-30       Impact factor: 1.710

6.  The role of ceruloplasmin in iron metabolism.

Authors:  H P Roeser; G R Lee; S Nacht; G E Cartwright
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

7.  Aceruloplasminaemia with progressive atrophy without brain iron overload: treatment with oral chelation.

Authors:  F M Skidmore; V Drago; P Foster; I M Schmalfuss; K M Heilman; R R Streiff
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-10-02       Impact factor: 10.154

Review 8.  Copper and iron disorders of the brain.

Authors:  Erik Madsen; Jonathan D Gitlin
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

9.  Case of presymptomatic aceruloplasminemia treated with deferasirox.

Authors:  Mayumi Tai; Nobuo Matsuhashi; Osamu Ichii; Tomohiro Suzuki; Yutaka Ejiri; Satoshi Kono; Tatsuhiro Terada; Hiroaki Miyajima; Masaru Harada
Journal:  Hepatol Res       Date:  2014-01-23       Impact factor: 4.288

10.  Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.

Authors:  Armin Finkenstedt; Elisabeth Wolf; Elmar Höfner; Bethina Isasi Gasser; Sylvia Bösch; Rania Bakry; Marc Creus; Christian Kremser; Michael Schocke; Milan Theurl; Patrizia Moser; Melanie Schranz; Guenther Bonn; Werner Poewe; Wolfgang Vogel; Andreas R Janecke; Heinz Zoller
Journal:  J Hepatol       Date:  2010-08-04       Impact factor: 25.083

View more
  6 in total

Review 1.  Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders.

Authors:  Vassilena Iankova; Ivan Karin; Thomas Klopstock; Susanne A Schneider
Journal:  Front Neurol       Date:  2021-04-15       Impact factor: 4.003

2.  Severe Protein-Calorie Malnutrition-Associated Hepatic Steatosis in a Woman Who Had Roux-en-Y Gastric Bypass for Morbid Obesity Thirteen Years Ago.

Authors:  Guriel N Kim; Sam Ho; David Saulino; Xiuli Liu
Journal:  Gastroenterology Res       Date:  2021-04-21

3.  Dementia as a core clinical feature of a patient with aceruloplasminemia.

Authors:  Farzad Ashrafi; Mehri Salari; Fatemeh Nouri; Fatemeh Shiravi
Journal:  Clin Case Rep       Date:  2022-03-13

4.  Brain iron accumulation on MRI revealing aceruloplasminemia: a rare cause of simultaneous brain and systemic iron overload.

Authors:  Firdaous Touarsa; Daoud Ali Mohamed; Behyamet Onka; Soufiane Rostoum; Najwa Ech-Cherif El Kettani; Meriem Fikri; Mohamed Jiddane
Journal:  BJR Case Rep       Date:  2022-09-12

5.  New mutation of the ceruloplasmin gene in the case of a neurologically asymptomatic patient with microcytic anaemia, obesity and supposed Wilson's disease.

Authors:  Mária Ondrejkovičová; Sylvia Dražilová; Monika Drakulová; Juan López Siles; Renáta Zemjarová Mezenská; Petra Jungová; Martin Fabián; Boris Rychlý; Miroslav Žigrai
Journal:  BMC Gastroenterol       Date:  2020-04-07       Impact factor: 3.067

6.  Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports.

Authors:  Lena H P Vroegindeweij; Agnita J W Boon; J H Paul Wilson; Janneke G Langendonk
Journal:  Orphanet J Rare Dis       Date:  2020-04-25       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.